The verified answer
As of Oct 2026, DEPLOY verifies Johnson & Johnson: 1 model, 3 deployments across 3 regions, 5 active incidents. 3 sources back the record.
CategorySurgical robots
Overview
Johnson & Johnson (NYSE: JNJ) is a global healthcare and pharmaceutical company with a surgical robotics division that develops the MONARCH platform for bronchoscopic procedures and the OTTAVA surgical robotics system. The company's robotics portfolio spans robotic-assisted surgery, Digital surgery, and minimally invasive interventions.
Verified record
- Verified deployments
- 3 deployments on file
- Active incidents
- 5 incidents on file
Key facts
Data & sources
Press releases
1
News coverage
1
Web sources
1
3 sources backing this record.View all →
Models (1)
View all models →Partnerships
Every company Johnson & Johnson has built with, alongside the ones only announced in a press release.
Most-frequent partners
- 1Ronovo Surgical1× joint1 total
- 2Ronovo Surgical1× joint
Most recent
- Ronovo Surgical x Johnson & Johnson2025-09-08with Ronovo Surgicaljust announced
- Johnson & Johnson x Ronovo Surgical2024-01-01with Ronovo Surgicaloperating
Johnson & Johnson on the deployment map
View the global map3 verified deployments across 3 regions, newest verified Jun 2025. Explore where Johnson & Johnson's robots are operating, by place and type.
View the full Johnson & Johnson deployment record →
Relationships
Explainers
Plain-language answers to the questions people ask about Johnson & Johnson, from DEPLOY’s explainer library. Each is written in the language of the question and cross-checked against this registry.
What is a surgical robot?
What is Johnson & Johnson Ottava?
Which surgical robot is most deployed?
Current leadership (1)
- Joaquin Duato CEO, Johnson & Johnsonreported, not verified
Safety record
5 incidents on record (3 moderate, 2 minor). Most recent: Jul 2026.
Most recent: Jul 2026
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Incidents affecting Johnson & Johnson (5)
- FDA clears Johnson & Johnson Ottava robotic surgical system for soft tissue surgeries2026-07-22 · Regulatory action
- FDA grants De Novo authorization to Johnson & Johnson OTTAVA robotic surgical system for multiple soft tissue procedures2026-07-22 · Regulatory action
- FDA clears J&J Ottava surgical robot for US launch following de novo submission2026-07-22 · Regulatory action
- FDA grants De Novo marketing authorization to J&J Ottava surgical robot2026-07-22 · Regulatory action
- Johnson & Johnson submits OTTAVA robotic surgical system to FDA for de novo classification2026-01-07 · Regulatory action
Includes incidents linked directly to this company, to its models, or to deployments of its models or under its operation. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.
Operator customers (1)
- Johnson & Johnson3 deployments
Recent coverage
Johnson & Johnson in third-party press
Peers
42 peers across 1 segment. Every Johnson & Johnson competitor derived from shared form-factor and application-domain edges.
surgical robot(42)
28 companies in this segment · moderately_concentrated (HHI 2056.2102191459944) · leader Mazor Robotics at 3317%
- Asensus Surgicaldirect competitor(inferred)strong
- Brain Navidirect competitor(inferred)strong
- Brainlabdirect competitor(inferred)strong
- CMR Surgicaldirect competitor(reported)strong
- Distalmotiondirect competitor(inferred)strong
- Intuitive Surgicaldirect competitor(inferred)strong
Mentioned on (20)
Registry pages whose text names Johnson & Johnson.
Companies (3)
Robots and products (2)
People (10)
Georges-Olivier Reymond, Kurt Azarbarzin, Massimiliano Colella, Joaquin Duato, David Rosa, Shlomo Ben Haim, Harel Gadot, Frederic Moll, Fred Moll, Kevin Lobo
Incidents (3)
FDA clears Johnson & Johnson Ottava robotic surgical system for soft tissue surgeries, FDA grants De Novo authorization to Johnson & Johnson OTTAVA robotic surgical system for multiple soft tissue procedures, Johnson & Johnson submits OTTAVA robotic surgical system to FDA for de novo classification
Financial state
- Reporting basis
- aggregator_estimate
- Lifecycle stage
- mature
- Counterparty risk class
- low
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Partnerships
2 total · 1 operating · 1 just announced
Every company Johnson & Johnson has built with, alongside the ones only announced in a press release.
Most recent
- Ronovo Surgical x Johnson & Johnson2025-09-08with Ronovo Surgicaljust announced
- Johnson & Johnson x Ronovo Surgical2024-01-01with Ronovo Surgicaloperating
Most-frequent partners
- 1Ronovo Surgical1× joint1 total
- 2Ronovo Surgical1× joint
All 2 partnerships
open in the atlas →- technology2025-09-08just announced
- Johnson & Johnson x Ronovo SurgicalwithRonovo Surgicaldevelopment2024-01-01operating
Acquisitions (1)
- acquired Auris Healthfull acquisition2019-04-01
Timeline
Every recorded move in Johnson & Johnson’s history, most recent first: funding rounds, partnerships, acquisitions, supply-chain starts, key hires, and press.
PartnershipJohnson & Johnson x Ronovo Surgical
2024-01-01Ronovo Surgical signed a strategic collaboration agreement with J&J MedTech to expand surgical technology access in China and advance the Carina robotic platform. J&J led Ronovo's $67M Series D funding round.
AcquisitionAcquired Auris Health
2019-04-01Acquired Auris Health (full_acquisition)
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Incident recordedJul 22, 2026
FDA clears Johnson & Johnson Ottava robotic surgical system for soft tissue surgeries
- Incident recordedJul 22, 2026
FDA grants De Novo authorization to Johnson & Johnson OTTAVA robotic surgical system for...
- Incident recordedJul 22, 2026
FDA clears J&J Ottava surgical robot for US launch following de novo submission
- Incident recordedJul 22, 2026
FDA grants De Novo marketing authorization to J&J Ottava surgical robot
- Verified media addedVerifiedJun 11, 2026
The Next Era of Surgery | J&J MedTech
Sources (3)
- https://www.jnj.com/media-center/press-releases/johnson-johnson-submits-ottava-robotic-surgical-system-to-the-u-s-food-and-drug-administration
- https://www.medtechdive.com/news/jnj-layoffs-auris-california-robotic/644544/
- https://www.fiercebiotech.com/medtech/jj-to-take-over-verb-surgical-its-robotics-venture-verily
Common questions
What is Johnson & Johnson?
What does Johnson & Johnson make?
Is Johnson & Johnson publicly traded?
Who competes with Johnson & Johnson?
Who is the CEO of Johnson & Johnson?
How can I invest in Johnson & Johnson?
Where is Johnson & Johnson headquartered?
Who owns Johnson & Johnson?
Where does Johnson & Johnson operate robots?
How many robots has Johnson & Johnson deployed?
Is Johnson & Johnson a top robotics company?
When was Johnson & Johnson founded?
Are there any incidents involving Johnson & Johnson?
Is Johnson & Johnson safe?
Methodology: Verified · 3 sources (1 primary) · last reviewed 2026-10-10
Verification posture
Verified
High confidence
Review state
Stable
Last reviewed 2026-10-10
Sources by quality tier
- 1
- primary-company-ir
- Company IR disclosure
- 1
- secondary-trade-publication
- Trade publication
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Johnson & Johnson.Peer companies
- DLR Institute of Robotics and Mechatronics6 models
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- Koninklijke Philips2 models
- LEM Surgical2 models
In the press
Recent coverage mentioning Johnson & Johnson from third-party publications. Automatically surfaced; not part of the verified registry record.
Johnson & Johnson: Keep Calm And Hold On
Johnson & Johnson (JNJ) Q3 2026 Earnings Call Transcript
Health Bellwether J&J Slumps As Middle East Conflict Hampers Medtech Sales
Johnson & Johnson stock fell early Tuesday as the conflict in the Middle East weighted on medical device sales. The post Health Bellwether J&J Slumps As Middle East Conflict…
Surgical Precision, Sustainable Returns: Johnson & Johnson Secures Its Cash Flow Runway
Johnson & Johnson posted Q3 revenue growth of 5.9% to $25.4 billion, raised guidance, and gained analyst support as its OTTAVA surgical system and talc settlement shape its…
三迭纪与强生签署合作与许可协议
36氪获悉，三迭纪（南京）医药科技股份有限公司宣布，公司及其全资子公司三迭纪（上海）医药科技有限公司已与强生（Johnson & Johnson）签署合作与许可协议。双方将���合开发新型口服药物。强生旗下风险投资机构强生创投（JJDC）同步对三迭纪进行股权投资。
3 Healthcare Dividend Stocks Offering More Than Just Income
AbbVie, Johnson & Johnson and Merck offer growing dividends alongside healthcare pipeline catalysts, regulatory approvals and rising analyst price targets heading into 2027.
The September Scramble: Find Sanctuary in These 3 Defensive Dividend Stocks
As Fed and inflation worries mount, Casey's General Stores, Johnson & Johnson, and PepsiCo stand out as defensive dividend payers with healthy balance sheets, growing payouts, and…
3 Healthcare Stocks for 3 Stages of Life
Healthcare stocks Eli Lilly, UnitedHealth Group, and Johnson & Johnson offer options for investors of different ages, combining growth potential, turnaround momentum, and reliable…
Johnson & Johnson is in talks to sell its orthopedics business to Apollo for $20 billion
5 Defensive Stocks to Watch as CPI and the Fed Put the Rally to the Test
Ahead of CPI data and the Fed's rate decision, defensive stocks McDonald's, Johnson & Johnson, Walmart, Berkshire Hathaway, and NextEra Energy offer stability and dividends amid…
J&J’s standardized surgical site classification system may improve patient outcomes
Johnson & Johnson MedTech recently unveiled a new global standardization system to measure surgical site outcomes in The British Journal of Surgery. The new DISH Classification…
Johnson & Johnson: Buy IMAAVY Label Expansion First And Continued CAPLYTA Sales Push
Machine-readable surfaces
- Markdown mirror: /companies/johnson-and-johnson.md
- RSS feed: /companies/johnson-and-johnson/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/766676f2-56d0-4910-81dc-03703d6c9c40
- Revision history: /companies/johnson-and-johnson/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- DLR Institute of Robotics and Mechatronics6 models
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- Koninklijke Philips2 models
- LEM Surgical2 models
Video
Former NFL star and three-time Pro Bowl running back Chris Johnson revealed he has been diagnosed with ALS, also known as Lou Gehrig's disease. Johnson said in an interview with Good Morning America co-anchor Michael Str
House Speaker Mike Johnson, R-La., discusses GOP efforts to advance a reconciliation bill and its top priorities on ‘Kudlow.’ #fox #media #breakingnews #us #usa
If our presumed next prime minister, Andy Burnham, wants to avoid the errors that saw off his recent predecessors, perhaps he should talk to the man who has wor
Dwayne Johnson admits that physically playing Maui gave him a deeper connection to the role's inspiration. #moana #maui #dwaynejohnson
House Speaker Mike Johnson discusses his trusted bond with President Donald Trump and weighs in on tensions with Senate Majority Leader John Thune. Read more:
Former Tennessee Titans player Chris Johnson announced his ALS diagnosis and called for a return of the Ice Bucket Challenge and several 10News employees take p
Here come the guests! A gaggle of Taylor Swift and Travis Kelce’s A-list attendees have made their way to New York City’s Madison Square Garden for the wedding
Speaker Mike Johnson says the pending housing bill will become law with or without President Donald Trump's signature. Read more: https://tinyurl.com/3emsv5m5
Speaker Mike Johnson says he hopes Iranians “come to their senses,” after President Trump warned the ceasefire was violated. Read more: https://tinyurl.com/mry
Following the Supreme Court's ruling that struck down President Trump's attempt to limit birthright citizenship, House Speaker Mike Johnson said the law is bein
House Speaker Mike Johnson sat for an exclusive interview with USA TODAY ahead of America's 250th anniversary. Read more: https://tinyurl.com/ma6x52v9 Sign u
JNJ stock analysis is vital right now as healthcare investors react to a massive shift in the company's core pharmaceutical portfolio. In this video, we break d
House Speaker Mike Johnson discusses the rise of socialism within the Democratic Party, efforts to pass the SAVE America Act and the likelihood of an additional
#enews #redcarpet #popculture About: The E! News team brings you the latest breaking entertainment, fashion and Pop Culture news. Featuring exclusive segments,
"We felt the importance of the moment." American mathematician Dr. Marion Lee Johnson is celebrating achievements in space — and recognizing American innovator
Approved Market: U.S. Introducing the OTTAVA Robotic Surgical System, the world's first table-integrated soft tissue robotic system. OTTAVA is purpose-built to
In this series, Johnson & Johnson MedTech highlights the faces, voices and inspiring stories of the employees around the world who are reimagining the way healt
Approved Market: U.S. Introducing the new DUALTO Energy System, an electrosurgical generator designed to offer simplified user experience, access to Polyphonic
How is digital technology transforming orthopedic surgery worldwide? 🌍 Join us in this exclusive conversation with Janardhan Ramachandran, Worldwide President
Approved Market: U.S. Johnson & Johnson MedTech’s MONARCH Platform, a robotically assisted bronchoscopy system, can improve how physicians reach and biopsy lun
Ever wondered what a day in the life of an Ethicon, Inc. Sales Training Representative is like? Take a look below and join our highly talented team today! Subs
White House correspondent Francesca Chambers interviews House Speaker Mike Johnson discusses Iran war, housing bill and America’s 250th anniversary Read more:
The **OTTAVA™ Robotic Surgical System**, developed by **Johnson & Johnson MedTech**, represents a new generation of robotic-assisted surgery designed to enhance
After a decade of development and a year of trials JNJ submits their Ottava system to FDA. A vast undertaking from Johnson & Johnson Medtech to get one step cl
Johnson & Johnson's MedTech division announced on Tuesday its plans to pursue FDA clearance in 2024 for commencing U.S. clinical trials for its Ottava robotic s
Approved Market: U.S The ETHICON GEN11 Generator combines advanced technology to support all HARMONIC Ultrasonic and ENSEAL Advanced Bipolar Devices through a
House Speaker Mike Johnson reflects on the tug-of-war between the legislative and executive branches in an exclusive USA TODAY interview. Read more: https://ti
Haoran Yu is advancing technology today that could save lives tomorrow. As Director of Robotics & Controls at J&J MedTech, Haoran is driven to take surgery to n
With so much unmet need in surgery, we're working to assist and empower surgeons to create better patient outcomes. Global Head of R&D, Robotics and Digital, Ne
Dr. Mullins shares how robotic assisted bronchoscopy can support your program and his learnings along his journey. Not a SAB Member? Join today! https://sabro
Heat Index
Serious54/100
A composite of competitive footprint, funding, press velocity, active partnerships, and supply-chain edges. Different from the Intelligence score below (which is per-form-factor productization). Non-robotics companies cap at 25.
Reality vs attention
Johnson & Johnson draws attention at the 99th percentile but verifies reality at the 61st percentile among surgical robots. Hype Gap +38.2, 9th widest among surgical robots.
6-month trend
Analysis
Broad public reach with 1.4M video views. Limited public funding data for capital position assessment.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Oct 17, 2026